Medical research

New anti-inflammatory molecule could halt MS progression

Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).

Alzheimer's disease & dementia

Impaired recovery from inflammation linked to Alzheimer's disease

(Medical Xpress)—New research from Karolinska Institutet shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease. A study published in the journal Alzheimer's ...

Oncology & Cancer

Stopping cancer in its tracks?

We've come a long way in cancer treatments – we have powerful, effective drugs for many types of cancer and we're moving toward ever more specific, less invasive therapies. But the problem with cancer is that it's always ...

Oncology & Cancer

Targeted cancer treatment: Cause of skin infections identified

Targeted, successful cancer treatments are very often accompanied by unpleasant side effects. Especially in anti-EGFR treatments the skin is often so badly affected by inflammations that patients consider breaking off the ...

Arthritis & Rheumatism

Reducing experimental inflammatory arthritis

(Medical Xpress)—UCD researchers led by Conway Fellow, Professor David Brayden in UCD School of Veterinary Medicine have successfully reduced inflammation in the swollen arthritic knees of a murine model using a novel nanoparticle.

Inflammatory disorders

A new 'on' signal for inflammation

(Medical Xpress)—Inflammation is an important response in the body - it helps you to kill off invaders such bacteria that could cause a harmful infection. But if it's chronic or uncontrolled, inflammation can also cause ...

page 6 from 9